Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background: Non-alcoholic fatty liver disease (NAFLD) includes simple steatosis and non-alcoholic steatohepatitis (NASH), with fibrosis in NASH serving as a critical prognostic marker. Objective: This study investigates the effects of Roux-en-Y gastric bypass (RYGB) on fibrotic NASH, assessed using the Fibrotic NASH Index (FNI). Methods: A retrospective cohort study was conducted involving 104 individuals (91.3% female, mean age 39.4 ± 8.6 years) who underwent RYGB. Histopathological evaluations during surgery identified fibrotic NASH, and FNI scores were calculated at baseline and one year post-surgery. Results: At the time of surgery, participants had a mean BMI of 35.3 ± 2.8 kg/m², which decreased to 27.1 ± 4.0 kg/m² one year after surgery. The mean % total weight loss (%TWL) was 23.8 ± 10.1%, and the mean % excess weight loss (%EWL) was 82.4 ± 37.3%. Fibrotic NASH was present in 17.3% of participants pre-operatively. The mean FNI score decreased significantly from 0.16 to 0.07 (p<0.0001) after surgery. Factors associated with improvement in the FNI included female gender (p=0.0009), higher alanine aminotransferase (ALT) levels (p=0.02), presence of lobular inflammation (p=0.03), and pre-operative histological evidence of fibrotic NASH (p=0.04). The FNI demonstrated high diagnostic accuracy (sensitivity: 61.1%, specificity: 96.4%, overall accuracy: 90.2%). Conclusion: RYGB effectively promotes the resolution of fibrotic NASH, highlighting its potential as a therapeutic intervention to mitigate progression to cirrhosis and hepatocellular carcinoma. The FNI is a reliable, non-invasive tool for assessing fibrotic NASH, warranting further research on its long-term impact on liver health.
Background: Non-alcoholic fatty liver disease (NAFLD) includes simple steatosis and non-alcoholic steatohepatitis (NASH), with fibrosis in NASH serving as a critical prognostic marker. Objective: This study investigates the effects of Roux-en-Y gastric bypass (RYGB) on fibrotic NASH, assessed using the Fibrotic NASH Index (FNI). Methods: A retrospective cohort study was conducted involving 104 individuals (91.3% female, mean age 39.4 ± 8.6 years) who underwent RYGB. Histopathological evaluations during surgery identified fibrotic NASH, and FNI scores were calculated at baseline and one year post-surgery. Results: At the time of surgery, participants had a mean BMI of 35.3 ± 2.8 kg/m², which decreased to 27.1 ± 4.0 kg/m² one year after surgery. The mean % total weight loss (%TWL) was 23.8 ± 10.1%, and the mean % excess weight loss (%EWL) was 82.4 ± 37.3%. Fibrotic NASH was present in 17.3% of participants pre-operatively. The mean FNI score decreased significantly from 0.16 to 0.07 (p<0.0001) after surgery. Factors associated with improvement in the FNI included female gender (p=0.0009), higher alanine aminotransferase (ALT) levels (p=0.02), presence of lobular inflammation (p=0.03), and pre-operative histological evidence of fibrotic NASH (p=0.04). The FNI demonstrated high diagnostic accuracy (sensitivity: 61.1%, specificity: 96.4%, overall accuracy: 90.2%). Conclusion: RYGB effectively promotes the resolution of fibrotic NASH, highlighting its potential as a therapeutic intervention to mitigate progression to cirrhosis and hepatocellular carcinoma. The FNI is a reliable, non-invasive tool for assessing fibrotic NASH, warranting further research on its long-term impact on liver health.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.